ADAR and esophageal squamous cell carcinoma: For example, in hepatocellular carcinoma and esophageal squamous cell carcinoma, ADAR1 overexpression leads to impaired A-to-I RNA editing at the M2269V site of silk protein B (FLNB), resulting in cytoskeletal changes.